Abstract
Beta-blockers are recommended as first-line symptomatic treatment for stable angina. However, their impact on mortality outside the context of myocardial infarction is unknown. We performed a meta-analysis of all randomized trials of beta-blockers in stable angina. Medical databases and cardiology journals were searched for relevant randomized clinical trials. The primary outcome was cardiovascular mortality, separately considering trials of beta-blockers versus placebo and beta-blockers versus other antianginals. We conducted a subgroup analysis on cardioselective versus non-cardioselective beta-blockers and calcium channel antagonists versus nitrates. We calculated odds ratios (ORs) and confidence intervals (CIs) using Peto's method. We found no statistically significant evidence that beta-blockers impact on mortality when compared with placebo (OR, 0.42; CI , 0.15-1.21) or other antianginals (OR, 0.98; CI, 0.86-1.10), or all others (OR, 0.97; CI, 0.86-1.09). There was a trend for cardioselective beta-blockers to have a greater improvement in mortality when compared with placebo and to have greater impact than non-calcium channel antagonists. Beta-blockers do not have statistically significant impact on mortality versus place...Continue Reading
References
Jan 1, 1977·British Journal of Cancer·R PetoP G Smith
Mar 1, 1985·Progress in Cardiovascular Diseases·S YusufP Sleight
Nov 1, 1988·European Heart Journal·S JohanssonL Wilhelmsen
Mar 26, 1982·JAMA : the Journal of the American Medical Association
Jun 1, 1999·JAMA : the Journal of the American Medical Association·P A HeidenreichM A Hlatky
Mar 14, 2000·JAMA : the Journal of the American Medical Association·A HjalmarsonP Deedwania
May 30, 2001·European Journal of Heart Failure·M C ShibataD Wang
Oct 23, 2002·Circulation·Milton PackerUNKNOWN Carvedilol Prospective Randomized Cumulative Survival (COPERNICUS) Study Group
Jul 9, 2004·Clinical Cardiology·J KarlssonH Melhus
May 10, 2005·BMJ : British Medical Journal·Julia Hippisley-Cox, Carol Coupland
Nov 22, 2005·Journal of the American Pharmacists Association : JAPhA·UNKNOWN Lewin Group
Jan 10, 2009·Journal of the American College of Cardiology·Adrian F HernandezGregg C Fonarow
Feb 13, 2009·Expert Review of Cardiovascular Therapy·Graziano Riccioni
Citations
Jun 21, 2014·BMJ Open·Yongliang Jia, Siu-Wai Leung
Jul 30, 2014·The Canadian Journal of Cardiology·G B John ManciniRodney Zimmermann
Jul 19, 2014·Journal of the American College of Cardiology·Charlotte AnderssonMark A Hlatky
Apr 23, 2014·The Canadian Journal of Cardiology·Pierre LarochelleYves Lacourcière
Apr 21, 2016·Tidsskrift for den Norske lægeforening : tidsskrift for praktisk medicin, ny række·Jan Erik OtterstadDag S Thelle
Feb 24, 2015·Lancet·Desmond G Julian, Stuart J Pocock
Jul 5, 2016·European Journal of Pharmacology·Louise E See HoeJason N Peart
Aug 20, 2016·JACC. Cardiovascular Interventions·Apurva A MotivalaDebabrata Mukherjee
Sep 4, 2016·International Journal of Cardiology·Mohammad JaradatJi Won Yoo
Sep 18, 2016·Cardiovascular Drugs and Therapy·Udho Thadani
Jan 26, 2017·Drugs·Talla A RousanUdho Thadani
Jan 1, 2017·Indian Heart Journal·Sundeep MishraV K Bahl
Mar 31, 2017·American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions·Csaba András Dézsi, Veronika Szentes
Oct 18, 2016·Current Opinion in Cardiology·Cheng SunZhe Zheng
May 28, 2019·European Cardiology·Talla A Rousan, Udho Thadani
Jun 4, 2021·Current Cardiology Reports·Francesco MoroniLorenzo Azzalini